-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Amgen Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Amgen Inc Operating Income (Loss) for the quarter ending March 31, 2024 was $991 M, a 48.4% decline year-over-year.
- Amgen Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was $6.97 B, a 22.5% decline year-over-year.
- Amgen Inc annual Operating Income (Loss) for 2023 was $7.9 B, a 17.4% decline from 2022.
- Amgen Inc annual Operating Income (Loss) for 2022 was $9.57 B, a 25.2% increase from 2021.
- Amgen Inc annual Operating Income (Loss) for 2021 was $7.64 B, a 16.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)